Correction to “Meta‐Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients with Metabolic Dysfunction‐Associated Steatotic Liver Disease”
Correction to “Meta‐Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients with Metabolic Dysfunction‐Associated Steatotic Liver Disease”. // Alimentary Pharmacology and Therapeutics. – 2026. – DOI: 10.1111/apt.71051. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.71051?af=R
(2026). Correction to “Meta‐Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients with Metabolic Dysfunction‐Associated Steatotic Liver Disease”. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.71051
“Correction to “Meta‐Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients with Metabolic Dysfunction‐Associated Steatotic Liver Disease”.” Alimentary Pharmacology and Therapeutics, 2026. doi:10.1111/apt.71051.
@article{article98682,
title = {Correction to “Meta‐Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients with Metabolic Dysfunction‐Associated Steatotic Liver Disease”},
journal = {Alimentary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/apt.71051},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apt.71051?af=R}
}